The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

OBIO FINANCIAL STATEMENTS

Orchestra BioMed Holdings Inc. — balance sheet, income statement and cash flow trends

OBIOOrchestra BioMed Holdings Inc.

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue32 M $Gross Profit31.8 M $ · 99%Operating Income-58 M $ · -181%Pre-tax Income-59 M $ · -185%Net Income to Owners-59 M $ · -185%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue32 M $+986.1%
Gross Profit31.8 M $+1,064.2%
Operating Income-58 M $—
EBITDA-57.1 M $—
Net Income to Owners-59 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
-100 M0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets115.7 M
  • Equity29.4 M $25%
  • Current Liabilities13.5 M $12%
  • Long-term Liabilities72.8 M $63%

Key Figures

YoY change
Total Assets115.7 M $+170.2%
Total Liabilities86.3 M $+102.9%
Total Equity29.4 M $+9,872.9%
Cash & ST Investments110 M $+224.1%
Total Debt70.8 M $+332.7%
Net Debt50.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-60 M-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-58.3 M $Operating-69.3 M $Investing129.3 M $Financing1.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-58.3 M $—
Capital Expenditures781 K $+144.1%
Free Cash Flow-59.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on OBIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.